Atlas Trials

Tocilizumab vs Azathioprine in Neuromyelitis Optica Spectrum Disorders

Clinical trial NCT03350633 · COMPLETED

Trial details

NCT number
NCT03350633
Sponsor
Tianjin Medical University General Hospital
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Neuromyelitis Optica Spectrum DisordersNeuromyelitis Optica
Start date
2017-11-01
Primary completion
2019-09-01
Enrollment
118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.